BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Abu Khalaf S, Albarrak A, Yousef M, Tahan V. Immune checkpoint inhibitors induced colitis, stay vigilant: A case report. World J Gastrointest Oncol 2020; 12(6): 699-704 [PMID: 32699584 DOI: 10.4251/wjgo.v12.i6.699]
URL: https://www.wjgnet.com/1948-5204/full/v12/i6/699.htm
Number Citing Articles
1
Ipilimumab/nivolumabReactions Weekly 2020; 1826(1): 185 doi: 10.1007/s40278-020-84632-7
2
Dua Abuquteish, Ahmad Yousef Alazzam, Aws Khalid Abushanab, Omar Amjad Almajdoubah, Sara Aljfout, Mahmoud Taysir Mousa, Mus’ab Theeb Mustafa, Bashar Khater, Maher Sughayer. Iatrogenic effect of immune checkpoint inhibitors and targeted therapies on the lower gastrointestinal tractFrontline Gastroenterology 2025; : flgastro-2025-103094 doi: 10.1136/flgastro-2025-103094
3
Shiyang Wang, Binhe Tian, Hanping Wang. Risk Factors and Prognostic Analysis of Immune Checkpoint Inhibitor-Related Colitis in Lung CancerJournal of Inflammation Research 2024; : 7535 doi: 10.2147/JIR.S482456
4
Xu Tong, Tao Zhan, Xiaoqin Dong, Dong Xu. Fever of unknown origin associated with immune checkpoint inhibitorsFrontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1364128